Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.56
+0.00 (0.00%)
AAPL  260.33
+0.00 (0.00%)
AMD  210.02
+0.00 (0.00%)
BAC  55.64
+0.00 (0.00%)
GOOG  322.43
+0.00 (0.00%)
META  648.69
+0.00 (0.00%)
MSFT  483.47
+0.00 (0.00%)
NVDA  189.11
+0.00 (0.00%)
ORCL  192.84
+0.00 (0.00%)
TSLA  431.41
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.